Combination of Biochanin A and Temozolomide Impairs Tumor Growth by Modulating Cell Metabolism in Glioblastoma Multiforme.

Abstract:

BACKGROUND/AIM:Several epidemiological studies have reported the chemopreventive potential of biochanin A, in cancer development and progression. We investigated the anticancer potential of combination of biochanin A and temozolomide against U-87 MG and T98 G [glioblastoma multiforme (GBM)] cells. MATERIALS AND METHODS:We evaluated the effect of biochanin A and temozolomide treatment on cell viability, expression of survival proteins, cell cycle, cell metabolism and mitochondrial function. RESULTS:Enhanced inhibitory effects of the combination treatment were observed on cell viability, expression of cell survival proteins EGFR, p-ERK, p-AKT, c-myc and MT-MMP1, and increased expression of the tumor suppressor, p-p53. Combination treatment also induced arrest in the G1 phase of the cell cycle. A shift in the metabolic phenotype of cells from glycolytic to oxidative phosphorylation was observed on combination treatment and the permeabilized cells showed a significant impairment in complex IV activity. CONCLUSION:Biochanin A significantly enhanced the anticancer efficacy of temozolomide in GBM cells.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Desai V,Jain A,Shaghaghi H,Summer R,Lai JCK,Bhushan A

doi

10.21873/anticanres.13079

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

57-66

issue

1

eissn

0250-7005

issn

1791-7530

pii

39/1/57

journal_volume

39

pub_type

杂志文章
  • Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancer.

    abstract::The relationship between apoptosis and chemosensitivity remains complex. We tested the chemosensitivity of 45 patients with advanced breast cancer (BC) ex vivo against anthracyclines (A: doxorubicin, epirubicin), taxanes (T: paclitaxel, docetaxel), cisplatin (DDP) and CMF and any correlation with the expression of p53...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rein DT,Schöndorf T,Breidenbach M,Janát MM,Weikelt A,Göhring UJ,Becker M,Mallmann P,Kurbacher CM

    更新日期:2000-11-01 00:00:00

  • Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is an aggressive KIT-positive cutaneous tumor. KIT mutations are considered to play a key role in the pathogenesis of various neoplasms, but have not been found so far in MCC. The aim of the present study was therefore to investigate the presence of KIT mutations in MCC. MATERIAL...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Krasagakis K,Metaxari M,Zervou M,Stathopoulos EN,Eberle J,Kanitakis J,Georgoulias V,Krüger-Krasagakis S,Tavernarakis N,Tosca AD

    更新日期:2011-03-01 00:00:00

  • Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase.

    abstract:BACKGROUND:Neutral endopeptidase 24.11 (NEP) is a cell-surface peptidase that inactivates a variety of neuropeptide substrates. In addition to catalytic activity, NEP can exert biological effects through protein-protein interactions. We previously reported that NEP directly associated with tyrosine-phosphorylated Lyn k...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shen R,Milowsky MI,Ozaki N,Navarro D,Sumitomo M,Xu Y,Nanus DM

    更新日期:2002-09-01 00:00:00

  • The tyrosine kinase inhibitor AG490 inhibits growth of cancer cells and activates ERK in LS174T and HT-29 cells.

    abstract:BACKGROUND:The activity of tyrosine kinases, although strictly regulated in normal cells, is often disturbed in cancer cells. The inhibition of a tyrosine kinase could be a target for treating cancer. MATERIALS AND METHODS:The colon cancer cell lines LS174T and HT-29 and the lung cancer cell line NCI-H292 were used. T...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Saito K,Iwashita J,Murata J,Abe T

    更新日期:2006-03-01 00:00:00

  • Creation of ultra-rare restriction sites in intact eucaryotic chromosomes mediated by bacterial methylases: an approach to sequencing and analyzing tumor and normal genomes.

    abstract::The limited restriction of eucaryotic chromosomes would facilitate our understanding of the aberrant genomes of genetic diseases and cancer. We have described methods for methylating eucaryotic chromosomes embedded in agarose plugs. We now describe how Cla I methylase can be utilized in a methylation-dependent restric...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Wilson WW,Mebane EW,Hoffman RM

    更新日期:1993-01-01 00:00:00

  • Enhanced renal clearance of vancomycin in rats with carcinogen-induced osteosarcoma.

    abstract::Recently, it has been reported that total clearance (CLtot) of vancomycin is significantly higher in patients with malignancies compared to those without malignancies. In the present study, to clarify the mechanism of this enhancement in malignancy, we adopted rat animal models, using chemical carcinogen-induced osteo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Shimada I,Iwata C,Taga S,Teramachi H,Nomura M,Miyamoto K,Tsuciya H,Wada T,Kimura K,Matsushita R

    更新日期:2012-03-01 00:00:00

  • Treatment of mice bearing a Krebs ascitic tumor by means of a protocol based on radioactive copper (64Cu). II. Analysis of the treatment.

    abstract::A new treatment is proposed for mice bearing a Krebs ascitic tumor targeting on both the malignant cells and the host cells having the "cancer functioning" (cancer cells) (Anticancer Res 9: 941-946 1989). It is shown that the treatment (a) injure specifically via 64Cu transmutation the DNA of the malignant cells and f...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Guillé E,Apelgot S

    更新日期:1989-07-01 00:00:00

  • Melting curve analysis for mutations of EGFR and KRAS.

    abstract::Epidermal growth factor receptor (EGFR) and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are common in non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The aim of the present study was to develop a simple and versatile tool to determine EGFR and KRAS mutations for pre-clinical r...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Furugaki K,Yasuno H,Iwai T,Moriya Y,Harada N,Fujimoto-Ouchi K

    更新日期:2014-02-01 00:00:00

  • Carcinoma of the axillary tail of Spence: a case series.

    abstract::There is sparse information about cancer in the axillary tail of Spence (CATS). Eight hundred and thirty-nine patients with breast cancer were retrospectively studied for the occurrence of CATS. Ten patients were identified based on detection by imaging studies. A tendency towards stage II or III disease, and estrogen...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ampil F,Caldito G,Henderson B,Li B,Kim RH,Burton G,Chu Q

    更新日期:2012-09-01 00:00:00

  • Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report.

    abstract::Anaplastic lymphoma kinase (ALK) gene re-arrangements are present in approximately 4% of patients with non-small cell lung cancer (NSCLC), mostly in non-smokers with adenocarcinoma. V-KI-RAS2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are more common in smokers. These molecular lesions were usually de...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Homa I,Sawicki M,Wojas-Krawczyk K,Nicoś M,Mlak R,Powrózek T,Krawczyk P,Przybylski P,Czekajska-Chehab E,Milanowski J

    更新日期:2014-07-01 00:00:00

  • Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin.

    abstract:BACKGROUND:The purpose of the present study was to correlate the nuclear expression of p53 and p21 with response to paclitaxel and carboplatin, progression-free survival (PFS) as well as overall survival (OS), in patients with urothelial metastatic transitional-cell carcinoma (TCC). PATIENTS AND METHODS:Histological s...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Flamm M,Brodowicz T,Haitel A,Susani M,Tomek S,Köstler W,Pycha A,Kratzik C,Marberger M,Zielinski CC

    更新日期:2002-03-01 00:00:00

  • Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.

    abstract::A prospective study was performed on a series of 42 patients with breast carcinoma. Immunocytochemical determination of receptors for estrogens (ER) and progesterone (PR) and flow cytometric DNA analysis (DNA-ploidy and the S-phase fraction) were performed on material obtained from fine-needle aspirates (FNA). The pat...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Marrazzo A,Russo A,Bazan V,Taormina P,Lupo F,Bazan P

    更新日期:1993-11-01 00:00:00

  • CEA as a prognostic factor in colorectal cancer.

    abstract::We have measured serum CEA levels in 207 patients with colorectal cancer. CEA sensitivity was related to tumor stage in tumors located in the right colon, but not in tumors located in the left colon or the rectum. CEA had prognostic value in patients with tumors located in the right colon (p < 0.001) but not in the le...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Filella X,Molina R,Piqué JM,Grau JJ,Garcia-Valdecasas JC,Biete A,Novell F,Astudillo E,Bordas JM,Campo E

    更新日期:1994-03-01 00:00:00

  • Cytofluorimetric analysis of a renal tubular cell line and its resistant counterpart.

    abstract::P-glycoprotein (P-gp) and multidrug resistance related protein (MRP) overexpression is often responsible of the development of multidrug resistance in cancer therapy. These proteins are also expressed in normal tissues, where their physiological role is related to the extrusion of endogenous toxins or to secretory fun...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rosati A,Decorti G,Klugmann FB,Candussio L,Granzotto M,Melato M,Giraldi T

    更新日期:2000-09-01 00:00:00

  • Quantitative Structure-Cytotoxicity Relationship of 2-Azolylchromones.

    abstract:BACKGROUND/AIM:Twenty-four 2-azolylchromones were subjected to quantitative structure-activity relationship (QSAR) analysis based on their cytotoxicity and tumor specificity, in order to find their new biological activities. MATERIALS AND METHODS:Cytotoxicity against two human oral squamous cell carcinoma cell lines a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12282

    authors: Sakagami H,Okudaira N,Uesawa Y,Takao K,Kagaya H,Sugita Y

    更新日期:2018-02-01 00:00:00

  • A Case of Vanishing Brain Metastasis in a Melanoma Patient on Nivolumab.

    abstract:BACKGROUND:Melanoma is among the top three cancers to present with brain metastasis. The risk of brain metastases in advanced melanoma increases with disease duration. Cytotoxic chemotherapy does not have a significant role in the management of melanoma patients with brain metastases, neither alone nor in conjunction w...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11038

    authors: Basnet A,Saad N,Benjamin S

    更新日期:2016-09-01 00:00:00

  • Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro.

    abstract:BACKGROUND:An acidic arabinogalactan from European mistletoe (Viscum album L, VAL; 1.34 x 10(6) Dalton) was studied in detail because its immunological properties are poorly characterised. MATERIALS AND METHODS:Flow cytometric studies focussed on PS-activated proliferation of human lymphocytes measured via incorporati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Stein GM,Edlund U,Pfüller U,Büssing A,Schietzel M

    更新日期:1999-09-01 00:00:00

  • Stomach-specific Biomarkers (GastroPanel) Can Predict the Development of Gastric Cancer in a Caucasian Population: A Longitudinal Nested Case-Control Study in Siberia.

    abstract:BACKGROUND/AIM:Atrophic gastritis (AG) is the most important risk condition for gastric cancer (GC). A panel of stomach-specific serum biomarkers: pepsinogen (PG) I, pepsinogen (PG) II, gastrin-17 (G-17), and IgG antibodies to H. pylori (HP-Ab) detects the extent and grade of AG. The aim of the present study was to ass...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kurilovich S,Belkovets A,Reshetnikov O,Openko T,Malyutina S,Ragino Y,Scherbakova L,Leja M,Paloheimo L,Syrjänen K,Voevoda M

    更新日期:2016-01-01 00:00:00

  • Effects of selenium on mouse mammary tumorigenesis and glutathione peroxidase activity.

    abstract::The effects of supplemental selenium on 7,12-dimethylbenz(a)anthracene (DMBA)-induced and murine mammary tumor virus (MuMTV)-induced mammary tumorigenesis were investigated in BALB/c mice. Selenium (4-10 ppm), administered in the drinking water, inhibited mammary tumor formation in DMBA-treated mice. The higher doses ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Medina D,Lane H,Shepherd F

    更新日期:1981-01-01 00:00:00

  • Induction of Apoptosis in Human Oral Keratinocyte by Doxorubicin.

    abstract:BACKGROUND/AIM:We have previously reported that doxorubicin (DXR) showed much higher cytotoxicity against human oral squamous cell carcinoma cell lines compared to normal human mesenchymal normal oral cells (gingival fibroblast, periodontal ligament fibroblast, pulp cell), yielding high tumor-specificity. However, we u...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11412

    authors: Sakagami H,Okudaira N,Masuda Y,Amano O,Yokose S,Kanda Y,Suguro M,Natori T,Oizumi H,Oizumi T

    更新日期:2017-03-01 00:00:00

  • Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.

    abstract:BACKGROUND/AIM:Identifying useful biomarkers is central to selecting optimal therapeutic strategies for esophageal squamous cell carcinoma (ESCC). Serum p53 antibody (S-p53Ab), squamous cell carcinoma antigen (SCC-Ag), and carcinoembryonic antigen (CEA) were investigated to evaluate the significance of single and combi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12419

    authors: Kunizaki M,Hamasaki K,Wakata K,Tobinaga S,Sumida Y,Hidaka S,Yasutake T,Miyazaki T,Matsumoto K,Yamasaki T,Sawai T,Hamamoto R,Nanashima A,Nagayasu T

    更新日期:2018-03-01 00:00:00

  • Influence of hypotonic stress on the biliary excretion of doxorubicin in Wistar and TR- rats.

    abstract::In tumor cells, doxorubicin (DOX) is excreted by P-glycoprotein (P-gp) and the multidrug resistance-associated protein (mrp). Both transporters might also be involved in cellular regulatory volume decrease (RVD). To study the hepatobiliary excretion of DOX during RVD, isolated livers of Wistar and multidrug resistance...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gaugg M,Haslmayer P,Jäger W,Thalhammer T

    更新日期:2001-07-01 00:00:00

  • MIB1 (Ki-67) expression in non-Hodgkin's lymphomas.

    abstract::The MIB1 monoclonal antibody which is used as a marker of cell proliferation was studied by immunohistochemistry on formalin-fixed and paraffin embedded biopsy specimens of lymph nodes in 40 high- and 46 lowgrade cases of non-Hodgkin's lymphomas (NHL) classified according to the Kiel classification. All cases were fou...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kalogeraki A,Tzardi M,Panagiotides I,Koutsoubi K,Bolioti S,Rontogianni D,Stefanaki K,Zois E,Karidi E,Darivianaki K,Delides G,Kanavaros P

    更新日期:1997-01-01 00:00:00

  • Nobody needs "relative tumour sizes" to compare tumour growth curves.

    abstract::Tumour growth curve experiments play an important role in experimental oncology and established methods exist for their unbiased interpretation. However, many authors till introduce systemic biases to their data by using the so-called "relative tumour size" transformation, inspite of wide awarance about the limitation...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Bassukas ID,Hofmockel G

    更新日期:2001-03-01 00:00:00

  • Nucleolar organiser regions (AgNORs) related to histopathological characteristics and survival in prostatic adenocarcinoma.

    abstract::The number of silver stained nucleolar organiser regions (AgNORs) was assessed in biopsy specimens of 78 patients with prostatic adenocarcinoma followed up for a mean of 15.6 years. The number of Ag-NORs was related to histological features, clinical stage, DNA ploidy, S-phase fraction (SPF) and clinical outcome. In 3...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Eskelinen M,Lipponen P,Syrjänen K

    更新日期:1992-09-01 00:00:00

  • Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.

    abstract::Thalidomide was recently suggested to be angiogenesis-inhibitor following the demonstration of its activity in a rabbit cornea micropocket model. The purpose of the present study was to test its efficacy in solid tumors in mice. B16-F10 melanoma and CT-26 colon carcinoma cells were injected subcutaneously, intravenous...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Gutman M,Szold A,Ravid A,Lazauskas T,Merimsky O,Klausner JM

    更新日期:1996-11-01 00:00:00

  • Prognostic Impact of Proximal Versus Distal Localization in Extremity Long Bone Osteosarcomas.

    abstract:BACKGROUND/AIM:This study aimed to identify the prognostic factors and outcomes of osteosarcoma (OS) located in proximal versus distal extremity long bones. PATIENTS AND METHODS:A nationwide cohort comprising all Norwegian high-grade OSs in extremity long bones between 1982 and 2009 was investigated. RESULTS:The univ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13365

    authors: Berner K,Bruland ØS

    更新日期:2019-05-01 00:00:00

  • MG132, a proteasome inhibitor, induced death of calf pulmonary artery endothelial cells via caspase-dependent apoptosis and GSH depletion.

    abstract::MG132, a proteasome inhibitor, has been shown to induce apoptotic cell death through formation of reactive oxygen species (ROS). Here, we evaluated the effects of MG132 on the growth of endothelial cells, especially calf pulmonary artery endothelial cells (CPAECs). MG132 dose-dependently inhibited the growth of CPAECS...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Han YH,Moon HJ,You BR,Yang YM,Kim SZ,Kim SH,Park WH

    更新日期:2010-03-01 00:00:00

  • Eliciting hyperacute xenograft response to treat human cancer: alpha(1,3) galactosyltransferase gene therapy.

    abstract::Xenograft hyperacute rejection in humans occurs as a secondary response to a cellular glycosylation incompatibility with most non-human mammalian species. A key component of hyperacute rejection, alpha(1,3)galactosyl (agal) epitopes present on the surface of most non-human mammal cells, is bound by host anti-agal IgG ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Link CJ Jr,Seregina T,Atchison R,Hall A,Muldoon R,Levy JP

    更新日期:1998-07-01 00:00:00

  • Use of daily low-dose carboplatin in radiotherapy for non-small cell lung cancer.

    abstract::The feasibility of using low-dose carboplatin (CBDCA) as a radiopotentiator in radiotherapy(RT) for non-small cell lung cancer(NSCLC) patients with unfavorable factors was studied. Fifteen patients with locally advanced and inoperable NSCLC were treated with RT in combination with daily 20 mg/m2 CBDCA. Twelve patients...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Satoh H,Ohara K,Fuji H,Ishikawa H,Yamashita YT,Kamma H,Ohtsuka M,Hasegawa S

    更新日期:1998-11-01 00:00:00